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Abbreviations 
AF: atrial fibrillation BMI: body mass index  
CABG: coronary artery bypass grafting  
COPD: chronic obstructive pulmonary disease  
DM: diabetes mellitus  
CVA: cerebrovascular accident  
CX: circumflex artery  
DIA: diagonal  
IABP: intra-aortic balloon pump  
LAD: left anterior descending artery  
LITA: left internal thoracic artery 
LMS: left main stem  
LVEF: left ventricular ejection fraction  
MI: myocardial infarction  
OPCAB: off-pump coronary artery bypass grafting  
PCI: percutaneous coronary intervention  
PSM: propensity score matching  
PVD: peripheral vascular disease  
RA: radial artery 
RCA: right coronary artery 
RCT: randomized controlled trial  
RITA: right internal thoracic artery 
RRT: renal replacement therapy  
SMD: standardized mean difference 
SW: sternal wound   
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Abstract (Word count: 239) 
Objective(s): We conducted a propensity score matching to determine whether the 
use of the right internal thoracic artery (RITA) confers a survival advantage when 
compared to the radial artery (RA) as second arterial conduit in coronary artery bypass 
grafting (CABG). 
Methods: The study population included a highly selected low risk group of patients 
who received the RITA (n=764) or the RA (n=1990) as second arterial conduit. We 
obtained 764 matched pairs that were comparable for all pre-treatment variables. 
Time-segmented Cox regression model that stratified on the matched pairs was used 
to investigate the effect of treatment on late mortality. 
Results: After a mean follow-up of 10.2±4.5 years (max 17.3 years), survival 
probabilities at 5, 10 and 15 years were 96.4±0.7% versus 95.4±0.7%, 91.0±1.1% 
versus 89.1±1.2% and 82.4± 1.9% versus 77.2± 2.5% in the RITA and RA groups 
respectively. During the first 4 years, RITA and RA were comparable in terms of 
mortality (HR 1.00; 95%CI 0.56-1.78; P=0.98). However, after 4 years RITA was 
associated with a significant reduction in late mortality (HR 0.67; 95%CI0.48-0.95; 
P=0.02). RITA was superior to RA when the experimental conduit was used to graft 
the left coronary system (HR 0.69;95%CI 0.47-0.99; P=0.04) but not the right coronary 
system (HR 0.98;95%CI 0.59-1.62; P=0.93) 
Conclusions: In a highly selected low-risk group of patients, the use of the RITA as 
second arterial conduit for the left coronary system was associated with better survival 
when compared to the RA. 
Keyword: coronary artery bypass grafting, multiple arterial grafting; propensity score 
matching ; survival 
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Central message: In a highly selected low-risk group of patients, the right internal 
thoracic artery used as second arterial graft for the left coronary system was 
associated with better survival when compared to the RA. 
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Perspective Statement: The choice of the right internal thoracic artery or radial 
artery as second conduit in patients undergoing CABG, remains controversial. In a 
highly selected low-risk group of patients, the right internal thoracic artery used as 
second arterial graft for the left coronary system was associated with better survival 
when compared to the RA.  
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Despite increasing recognition that multiple arterial conduits improve long-term 
outcomes following coronary artery bypass grafting (CABG) [1], the quest for the 
second best arterial conduit to supplement the left internal thoracic artery continues 
[2]. In particular, whether the use of the right internal thoracic artery (RITA) confers a 
survival advantage when compared to the radial artery (RA) still needs to be 
determined [3]. To date, only a single randomized controlled trial (RCT) [3] has been 
published in the literature, largely underpowered to detect any difference in long term 
survival between RITA and RA groups. Several observational studies comparing RITA 
versus RA have been reported with conflicting findings [5-12]. Propensity score 
matching (PSM) based analysis of observational data is emerging as  an attractive 
alternative in view of paucity of evidence from RCT, and can be relied  upon as 
evidence when RCTs are not possible [4].  Recently general recommendations have 
been proposed in conducting PSM [13-15]. We aimed to compare short term outcomes 
and long term survival in patients receiving RITA versus RA as second arterial conduit 
by conducting a single centre 15 years outcomes PSM comparison in accordance with 
current recommendations.   
 
Methods 
The study was conducted in accordance with the principles of the Declaration of 
Helsinki. The local audit committee approved the study, and the requirement for 
individual patient consent was waived. We retrospectively analysed prospectively 
collected data from The National Institute for Cardiovascular Outcomes Research 
(NICOR) NACSA registry on 1 June 2015 for all isolated first time CABG procedures 
performed at the Bristol Heart Institute, Bristol United Kingdom from April 1996 to April 
2015.  Reproducible cleaning algorithms were applied to the database, which are 
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regularly updated as required. Briefly, duplicate records and non-adult cardiac surgery 
entries were removed; transcriptional discrepancies harmonized; and clinical conflicts 
and extreme values corrected or removed. The data are returned regularly to the local 
units for validation.  
Further details and definition of variables are available at 
http://www.ucl.ac.uk/nicor/audits/adultcardiac/datasets. Among 15119 isolated first 
time CABG cases performed during the study period, we selected subjects who met 
the following criteria: multivessel coronary disease including left main and/or left 
anterior descending (LAD) coronary disease; requiring at least 2 grafts; CABG 
performed by using the following strategies: left internal thoracic artery (LITA) used as 
in-situ to graft the LAD territory and RA graft the non-LAD territory with or without 
additional SV grafts (RA group) or both LITA and RITA with or without additional SV 
grafts as required in both groups (Supplementary Figure 1). Patients receiving both 
the RITA and the RA (n=275) were excluded from the present analysis. In the present 
series, the RITA and the RA were used only in case of target stenosis ≥75%.The RA 
was used as a free graft directly connected to the ascending aorta. The internal 
thoracic artery was harvested as a pedicle in all cases and was used as in situ graft 
that remained proximally connected to its respective subclavian artery or as a free 
graft proximally connected to other internal thoracic artery.  
Pre-treatment variables and study end-points  
The effect of adding the RA as third arterial conduit instead of SV was adjusted for the 
following variables including: age, gender, body mass index (BMI); previous 
myocardial infarction (MI), previous percutaneous coronary intervention (PCI); 
diabetes mellitus (DM) orally treated or on insulin; chronic obstructive pulmonary 
disease (COPD); current smoking; serum creatinine ≥200 mmol/l, previous 
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cerebrovascular accident (CVA); peripheral vascular disease (PVD); preoperative 
atrial fibrillation (AF); left main disease (LMD); non-LAD vessel diseased including 
Diagonal (DIA); circumflex artery (CX); right coronary artery (RCA); left ventricle 
ejection fraction (LVEF), non elective priority, off-pump coronary artery bypass 
(OPCAB), procedure performed by resident versus attending surgeon and logistic 
Euroscore.  
Short term outcomes investigated were 30-day mortality, need for post-operative intra-
aortic balloon pump (IABP), re-exploration for bleeding, renal replacement therapy 
(RRT) and sternal wound reconstruction. Long term outcome was all-cause mortality. 
All-cause mortality is the most robust and unbiased index because no adjudication is 
required; thus, inaccurate or biased documentation or clinical assessments are 
avoided [16]. Information about death was obtained from the institutional database 
and the National General Register Office for all patients. Follow-up was completed for 
all patients (100%). 
 
Statistical analysis 
For baseline characteristics, variables are summarized as mean for continuous 
variables and proportion for categorical variables. Multiple imputation was used to 
address missing data (Supplementary Table 1 and Supplementary Figure 2) 
(http://www.jstatsoft.org/v45/i07/). To control for measured potential confounders in 
the data set, a propensity score (PS) was generated for each patient from a 
multivariable logistic regression model based on pre-treatment covariates as 
independent variables with treatment type (RITA vs RA) as a binary dependent 
variable according to current recommendations [13,15]. The resulting propensity score 
represented the probability of a patient receiving the RITA as second arterial conduit. 
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As the PS model achieved a good discriminatory power C-statistic =0.74; 
Supplementary Figure 3), no attempt was made to include interactions or non-linear 
terms. Pairs of patients receiving RITA and RA were derived using greedy 1:1 
matching with a calliper of width of 0.2 standard deviation of the logit of the PS [14] 
(http://CRAN.Rproject.org/package=nonrandom) . The quality of the match was 
assessed by comparing selected pre-treatment variables in propensity score– 
matched patient using the standardized mean difference (SMD), by which an absolute 
standardized difference of greater than 10% is suggested to represent meaningful 
covariate imbalance [13-15]. Analytic methods for the estimation of the treatment 
effect in the matched sample were selected. McNemar’s was used to compare 
postoperative complications rate in the two groups [13]. In the primary Kaplan–Meier 
analysis, comparing late survival between the two groups, it was found that the curves 
crossed thus showing that the proportional hazards assumption was violated and the 
hazard was not constant with time. To evaluate the trends in this Kaplan–Meier curve, 
time-segmented Cox regression models before and after the curves crossed [17] 
stratified on the matched pairs [18] were used to investigate the effect of treatment 
(RITA vs RA) on early and late mortality phases. This approach accounts for the within-
pair homogeneity by allowing the baseline hazard function to vary across matched 
sets (http://CRAN.R-project.org/package=survival). Schoenfeld residuals test was 
used to confirm the non-violation of the proportional hazard assumption in the two 
separate Cox models. Subgroup analysis on late mortality according to the 
experimental conduit target, RITA configuration and OPCAB usage was carried out by 
mains of covariate adjustment using the propensity score on the overall sample to 
account for the relatively small sample size. Finally, due to the different distribution in 
OPCAB rate across the years (Supplementary Figure 4), the treatment effect was 
10 
 
adjusted for the interaction between OPCAB and year of surgery. Due to the highly 
selected low risk population, frailty models were not used. All p-values <0.05 were 
considered to indicate statistical significance. All statistical analysis was performed 
using R Statistical Software (version 3.2.3; R Foundation for Statistical Computing, 
Vienna, Austria). 
Results 
The study population included 764 low-risk subjects who received RITA with (n=482) 
or without (282) additional SV grafts and 1990 subjects who received the RA with 
(n=1206) or without (784) additional SV grafts. Patients characteristics distribution 
before and after PS matching are summarized in Table 1. In the unmatched group, RA 
tended to present a higher burden of comorbidities. In particular they were more likely 
to be older and female and to have a BMI ≥30, COPD and diabetes (both orally treated 
and on insulin) and impaired left ventricular function.  OPCAB rate was higher in the 
RA group (video 1). After matching the 764 matched pairs groups were comparable 
for all pre-treatment variables (SMD<10, Figure 1).  
Arterial graft configuration  
Mean number of graft performed were 2.87±0.76 in the RITA group versus 2.80±0.70 
and 2.87±0.70 in the unmatched (P=0.003) and matched (P=0.1) RA groups 
respectively. Grafts target in the unmatched and matched groups are summarized in 
Table 2. The RITA was used to graft the CX territory in 319(42%), the RCA territory in 
245(32%) cases and the LAD territory in 200 (26%) cases. Overall,  the CX territory 
was grafted by using an internal thoracic artery in 519(68%) cases The RA was used 
to graft the CX territory in 1530(77%) and 565(74%), the RCA territory in 460(23%) 
and 199 (26%) cases in the unmatched and matched RA groups respectively. RITA 
was used as a Y-graft in 144 cases and as in-situ graft in the remaining 620 cases.  
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Short term outcomes 
Short term outcomes in the matched samples are summarized in Table 2. The two 
groups were comparable in terms of 30-day mortality, incidence of cerebrovascular 
accident, need for renal replacement therapy. However, we found a trend towards a 
higher rate of re-exploration for bleeding, sternal wound reconstruction and need for 
postoperative IABP in the RITA group, although the overall incidence of these 
complication was relatively low.  Hospital stay length tended to be increased in the 
RITA group.  Short term outcomes in the unmatched RA group is reported in 
Supplementary Table 2.   
Mortality 
In the PS matched group, mean time to follow-up was 10.2±4.5 years (max 17.3 years) 
and 10.1±5.1 years and 10.3±3.7 in the RITA and the matched RA group respectively 
(P=0.31).  A total of 85 and 106 deaths in the RITA and RA groups respectively were 
recorded.  Survival probabilities at 5, 10 and 15 years were 96.4±0.7% versus 
95.4±0.7%, 91.0±1.1% versus 89.1±1.2% and 82.4± 1.9% versus 77.2± 2.5% in the 
RITA and RA groups respectively. The two survival curves crossed at 4 years 
(96.9±0.6 respectively, Figure 2). During the first 4 years, RITA and RA were 
comparable in terms of mortality (HR 1.00; 95%CI 0.56-1.78; P=0.98). However, after 
4 years RITA was associated with a significant reduction in late mortality (HR 0.67; 
95%CI0.48-0.95; P=0.02). Schoenfeld residuals test excluded proportional hazard 
assumption violation (P=0.93, Supplementary Figure 5).Survival rate in unmatched RA group 
is reported in Supplementary Figure 6.    
Subgroup analysis on late mortality (after 4 years) 
Subgroup analysis suggested that RITA was superior to RA in term of late survival 
when the experimental conduit was used to graft the left coronary system (HR 
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0.69;95%CI 0.47-0.99; P=0.04) but not the right coronary system (HR 0.98;95%CI 
0.59-1.62; P=0.93) (Figure 3). In cases with the experimental conduit grafted on the 
right coronary system only, neither in-situ RITA (HR 0.76; 95%CI 0.42-1.36; P=0.1) or 
free RITA (HR 1.78; 95%CI 0.89-3.56; P=0.3) were significantly associated with a 
better late survival when compared to the RA (Supplementary Figure 7).  
On the other hand, in cases with the experimental conduit grafted on the left coronary 
system only, we could not demonstrate any significant difference between free-RITA 
over in-situ RITA (HR 0.55; 95%CI 0.21-1.43; P=0.22; Figure 4). No significant 
difference in late mortality could be demonstrated between RITA grafted to the 
circumflex artery (with LITA to LAD) when compared to RITA grafted to the LAD 
territory (with LITA to circumflex artery) (HR 0.71;95%CI 0.34-1.43; P=0.33). When 
subjects receiving sequential grafts were excluded, the use of RITA to graft the left 
coronary system was still found to be superior to the RA (HR 0.65; 0.43-0.99; P=0.04). 
Finally the protective effect of RITA over RA on late mortality was confirmed when 
adjusted for the interaction between OPCAB and era of surgery (HR 0.73; 95%CI 0.54-
0.99; P=0.04).  
Discussion  
The present single centre long term PSM analysis, showed that in a low risk 
population, the use of the RITA when compared with the RA as second arterial conduit 
was associated with superior long term survival in patients undergoing CABG. This 
trend became to appear evident beyond 4 years. However, we found that the 
superiority of the RITA was evident only when the experimental conduit was used to 
graft the left coronary system. When used to graft the left coronary system free RITA 
and in-situ RITA showed comparable long term survival. Survival after RITA to LAD 
graft did not significantly differ from RITA to circumflex artery graft.   
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The use of RITA over the RA did not significantly increase operative mortality (within 
30 days) and the incidence of postoperative cerebrovascular accident or need for renal 
replacement therapy. However, we found a trend towards an increased incidence of 
re-exploration for bleeding, IABP requirement and sternal wound complication 
requiring reconstruction in patients receiving the RITA. However, the overall incidence 
of these complications was relatively low partially due to the low risk profile of the study 
population.  
In spite of a slow initial adoption, multiple arterial grafting is now widely advocated by 
the cardiovascular community [1]. The use of both RITA and RA has been showed to 
be associated with better long term survival when compared to the traditional strategy 
with a single internal thoracic artery and additional saphenous vein grafts [9].  
Controversy still remains, on whether the use of the RA as second arterial conduit 
achieves the same long-term benefits as that documented with the use of the RITA [5-
12].  The lack of clear evidence, the potentially increased sternal wound complication 
rate and the perceived technical complexity by using bilateral internal thoracic arteries 
often result in the RA as the preferred second conduit of choice [1]. The only 
randomized direct comparison in the literature is the Radial Artery Patency and Clinical 
Outcome (RAPCO) [3] which randomized 196 patients to the RITA and 193 patients 
to the RA. At midterm follow-up no significant differences in terms of angiographic 
patency and clinical outcome were found. However, the trial was largely underpowered 
to detect significant differences in survival between the two groups.  
PSM is emerging as an attractive alternative in view of paucity of evidence from RCT 
[4]. Recently, conflicting results have been reported on the superiority of the RITA over 
the RA from several PSM studies. Schwann et al. [9] reported on 551 propensity 
matched RITA and RA their conclusions supported the equipoise between RITA and 
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RA as the best-second arterial conduit. However, it should be noted that their analysis 
showed a clear trend towards a better survival by using RITA over RA (HR 1.35 0.98–
1.81). Shi et al. [10] performed a PSM on 318 matched pairs of patients receiving RITA 
versus RA. They demonstrated a marginally significant survival benefit from RITA (HR 
0.78; 95%CI 0.60-1.00; P=0.048).  On the contrary, Tranbaugh  et al [11], reported on 
528 pairs who received either a RA a free RITA to bypass the circumflex coronary. 
Ten-year survival was 85% for RA and 80% for RITA patients, which was not 
statistically significant (P=0.06) RA patency (83.9%) was similar to RITA patency 
(87.4%) (P= 0.15).It should be noted that in their series, the RITA was used as free 
graft directly connected to the aorta in 42% of cases and the mismatch in calliper 
between the aorta and the RITA might have affected its patency thus abolishing any 
survival advantage.  
By conducting a single centre 15 years PSM on 764 pairs of patients receiving RITA 
versus RA as second arterial conduit, we found that the use of the RITA is associated 
with a significant risk reduction of mortality after 4 years but this benefit is more likely 
to be relevant only when the RITA is used to graft the left coronary system. These 
findings are supported by previous studies which suggested that for bilateral ITA 
grafting to improve long-term outcomes over single ITA-to-LAD grafting, the second 
ITA should bypass the circumflex artery rather than the right coronary artery [19-21]. 
Schmidt and colleagues [19] observed long-term survival of 93% when both ITAs were 
used to bypass left-sided coronary arteries but only 70% when grafted to the RCA 
system after a mean follow-up of 9.2 years (P=0.02). Carrel [20] and Pick [21] have 
separately reported that using both ITAs to graft left-sided coronaries may increase 
survival over single ITA revascularization. These observations may reflect the lower 
patency of ITA grafts when used to bypass the RCA system compared with left-sided 
15 
 
coronary arteries. Grafts to the three different coronary artery territories have different 
patency rates which have been clearly demonstrated for individual ITA grafts [22]. 
Robinson et al [23] recently reported on postdischarge angiography of 296 free RITA 
as y graft including a total of 1,174 individual anastomoses examined. There were 428 
anterior wall (36.5%), 411 lateral wall (35.0%), and 335 inferior wall (28.5%) 
anastomoses. The patency rates for these were 90.6%, 83.9%, and 62.3%, 
respectively. 
In contrast, Kurlansky et al. [24] compared 1,479  RITA used to revascularize the left 
coronary system versus 736 RITA used to graft the right coronary system and they 
found similar survival after a mean follow-up of 12 years. In their series, in-situ grafting 
was used in the majority of cases (approximately 98% of arteries grafted) and when 
using the RITA to the right coronary artery, efforts were made to graft severely 
stenosed vessels and distal branches rather than the main RCA. In this context, Sabik 
at al. [25] were able to document equivalent long-term results with the use of the RITA, 
whether applied to the left or right coronary system. Their findings of similar survival 
whether the RITA was used to bypass the RCA or Cx system were attributable to 
careful patient selection. In fact, two important factors used in selecting the right 
coronary artery as the site for the RITA were (1) stenosis 70% to 90% with viable 
myocardium in its distribution; and (2) freedom from distal stenosis. Therefore they 
were likely to graft a RCA with RITA only when the likelihood of the RITA graft 
remaining patent, and therefore effective, was high.  
We could not demonstrate a superiority of in-situ over y graft RITA configuration when 
RITA was used to graft the left coronary system. This result is supported a recent 5-
year angiographic follow-up by Hwang et al. [26] on 398 patients who underwent 
OPCAB with in-situ RITA (n=164) graft or free RITA Y-composite graft (n=234) used 
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to graft the left coronary system. They found that  5-year patency rate was 92.5% vs 
92.4% for in-situ RITA and free RITA graft respectively (p=0.97). Finally, we found that 
in situ RITA to LAD was a valid alternative to in situ LITA to LAD when performing CABG using 
bilateral ITAs grafting on the left coronary system being associated with similar survival rates. 
RITA to LAD strategy represents an easily reproducible and technically less demanding 
strategy compared with other configurations. The RITA is biologically identical to the LITA and 
excellent angiographic results have been reported for RITA to LAD grafts [22]. Tatoulis and 
colleagues [27] reported a 95% 10-year patency rate for 149 RITA to LAD grafts and this result 
was comparable with LITA to LAD grafts (96%). In a previous series, we have demonstrated 
similar survival rate and freedom from re-intervention between RITA to LAD versus LITA to 
LAD in the context of bilateral ITA grafting [27].  
Although in this low risk population, operative complication were particularly low in 
both groups, the use of RITA was associated6 with an increased surgical morbidity 
including increased risk of re-exploration for bleeding, need for intra-aortic balloon 
pump and sternal wound reconstruction and prolonged hospital stay length. Inability 
to control bleeding from branches of the retrocaval and retroaortic routed RITA, which 
are in spasm at the time of closure and bleed later because of vasodilatation, as well 
as an increased number of potential bleeding sites due to construction of the Y-graft 
are some of the plausible reasons for the higher rate of re-exploration in the RITA 
group [28]. Moreover, retrocaval and transverse sinus routing of the RITA might 
compromise graft flow because of undetected kinks, graft overstretching, and rotation, 
which can partially account for the increased need of IABP [28]. Finally the use of RITA 
was confirmed to increase the risk of sternal wound reconstruction. In the present 
series a pedicled harvesting technique was used in all cases and this might account 
for this result and better results are anticipated by using skeletonized technique [29]. 
Taking into account the observed increased operative morbidity associated with the 
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RITA and based on the observation that the beneficial impact on survival from the 
RITA may be delayed by as much as 7 to 10 years [30], it seems reasonable to 
consider the RA as a valid option in older patients or patients with greater number of 
risk factors such as diabetes, obesity [31].  
The present analysis has intrinsic limitations. The main limitation of our study is that 
no follow-up data were available to compare the groups with respect to the cause of 
death (cardiac vs noncardiac), recurrence of angina, need for repeated 
revascularization, and graft patency. Therefore we can only speculate that the 
mechanism beyond the better long-term survival observed in our RITA group is related 
to the better patency rate of the RITA over the RA. Propensity technique can adjust 
only for measurable and included variables and we cannot exclude a selection bias 
based on non-measurable “eye-ball” variables (with the RITA reserved to healthier and 
better patients).  
In conclusion, we found that in a highly selected low-risk group of patients, the use of 
the RITA as second arterial conduit for the left coronary system was associated with 
better survival when compared to the RA.  
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Table 1. Pre-treatment variables distribution in the RITA group and in the unmatched 
and matched RA group  
  
RIMA 
 
N=764 
unmatched RA 
 
N=1990 
PSM RA 
 
N=764 
SMD  
before 
PSM 
SMD 
after 
PSM   
n % n % n % 
  
Age mean,ds 57±9 61±9 58±8 -44.6 -4.1  
<60 501 65.6 859 43.2 453 59.3 
  
                                60-69 213 27.9 797 40.1 254 33.2 
  
                                70-79 41 5.4 303 15.2 55 7.2 
  
                                ≥80 9 1.2 31 1.6 2 0.3 
  
          
Female                          No 710 92.9 1727 86.8 711 93.1 -20.5 -0.5 
                                Yes 54 7.1 263 13.2 53 6.9 
  
          
BMI mean,sd 28±3 29±4 28±4 -23.7 -2.9  
<30 597 78.1 1318 66.2 568 74.3 
  
                                ≥30 167 21.9 672 33.8 196 25.7 
  
          
MI                              No 447 58.5 1096 55.1 443 58.0 -6.9 -1.1 
                                Yes 317 41.5 894 44.9 321 42.0 
  
          
PCI                              No 725 94.9 1883 94.6 726 95.0 1.2 0.6 
                                Yes 39 5.1 107 5.4 38 5.0 
  
          
DM                              no 725 94.9 1635 82.2 715 93.6 -35.4 -1.1 
                                 Orally treated 17 2.2 212 10.7 34 4.5 
  
                                On insulin 22 2.9 143 7.2 15 2.0 
  
          
Current Smoking                         No 631 82.6 1677 84.3 621 81.3 -4.5 -3.4 
                                 Yes 133 17.4 313 15.7 143 18.7 
  
          
Creatinine>200mmol/l No 760 99.5 1986 99.8 763 99.9 5.4 6.9 
                                Yes 4 0.5 4 0.2 1 0.1 
  
          
COPD                            No 726 95.0 1813 91.1 728 95.3 -15.5 -1.2 
                                Yes 38 5.0 177 8.9 36 4.7 
  
          
CVA                             No 754 98.7 1939 97.4 752 98.4 -9.1 -2.2 
                                Yes 10 1.3 51 2.6 12 1.6 
  
          
PVD                             No 716 93.7 1853 93.1 718 94.0 2.4 1.1 
                                Yes 48 6.3 137 6.9 46 6.0 
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AF                              No 754 98.7 1938 97.4 752 98.4 -9.4 -2.2 
                                Yes 10 1.3 52 2.6 12 1.6 
  
          
LVEF                            ≥50% 646 84.6 1587 79.7 647 84.7 -13.4 0 
                                30%-49% 109 14.3 359 18.0 107 14.0 
  
                                <30% 9 1.2 44 2.2 10 1.3 
  
          
Preoperative IABP                        No 763 99.9 1988 99.9 763 99.9 -0.9 0 
                                 Yes 1 0.1 2 0.1 1 0.1 
  
          
OPCAB                           No 421 55.1 617 31.0 380 49.7 -50.2 -9.8 
                                Yes 343 44.9 1373 69.0 384 50.3 
  
          
Non elective priority                    No 427 55.9 1176 59.1 421 55.1 6.5 1.6 
                                Yes 337 44.1 814 40.9 343 44.9 
  
          
Performed by resident                         No 419 54.8 1423 71.5 435 56.9 35.1 4.2 
                                 Yes 345 45.2 567 28.5 329 43.1 
  
          
Logistic EuroSCORE mean,sd 2%±2% 
 
2%±3% 
 
2%±2% 
 
-19.2 -0.7  
<1.0% 233 30.5 369 18.5 220 28.8 
  
                                1.0%-1.9% 318 41.6 816 41.0 336 44.0 
  
                                2%-2.9% 114 14.9 391 19.6 124 16.2 
  
                                ≥3.0% 99 13.0 414 20.8 84 11.0 
  
          
Year of surgery 1996-1999 289 37.8 160 8.0 99 13.0 -33.3 -7.8 
                                2000-2004 190 24.9 743 37.3 338 44.2 
  
                                2005-2009 133 17.4 835 42.0 274 35.9 
  
                                2010-2015 152 19.9 252 12.7 53 6.9 
  
          
LMD                             No 587 76.8 1502 75.5 576 75.4 3.2 3.4 
                                Yes 177 23.2 488 24.5 188 24.6 
  
          
LAD                             No 4 0.5 25 1.3 4 0.5 7.8 0 
                                Yes 760 99.5 1965 98.7 760 99.5 
  
          
RCA                             No 220 28.8 701 35.2 220 28.8 13.8 0 
                                 Yes 544 71.2 1289 64.8 544 71.2 
  
          
CX                              No 151 19.8 379 19.0 136 17.8 1.8 5 
                                Yes 613 80.2 1611 81.0 628 82.2 
  
          
DIA                             No 599 78.4 1511 75.9 598 78.3 -5.9 -0.3 
                                Yes 165 21.6 479 24.1 166 21.7 
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RITA: right internal thoracic artery; RA: radial artery; PSM: propensity score matched; SMD: 
standardized mean difference; BMI: body mass index; MI: myocardial infarction; PCI: percutaneous 
coronary intervention; DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; CVA: 
cerebrovascular accident; PVD: peripheral vascular disease; AF: atrial fibrillation; LVEF: left ventricular 
ejection fraction; IABP: intra-aortic balloon pump; LMS: left main stem; LAD: left anterior descending 
artery; RCA: right coronary artery; CX: circumflex artery; DIA: diagonal; OPCAB: off-pump coronary 
artery bypass grafting.  
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Table 2. Arterial graft target and configuration 
 * LITA has been used to graft the LAD as in-situ graft; †RITA proximally connected 
to the LITA (y graft); ‡ LITA has been used to graft the CX as in-situ graft 
RITA: right internal thoracic artery; RA: radial artery; LITA: right internal thoracic 
artery; CX: circumflex artery; RCA: right coronary artery.  
 
  
RITA target 
 
(N=764) 
RA target  
Unmatched 
(N=1990) 
RA target 
Matched  
 (N=764) 
RCA as in-situ graft=198(26%)* 
RCA as free graft=47(6%)*† 
CX as in-situ graft (retro-aortic)=232(31%)* 
CX as free graft=87(11%)*† 
LAD as in-situ graft =190(25%)‡ 
LAD as free graft=10(1%)†‡ 
sequential grafts=46(6.0%) 
RCA=460(23%)* 
CX=1530(77%)* 
sequential grafts=130(6.5%) 
RCA=197(26%)* 
CX*=567(74%)* 
sequential grafts=46(6.0%) 
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Table 3. Short term outcomes  
                             
RIMA 
N=764 
 
PSM RA 
N=764 
 
P-
value  
     n %  n  %    
Mortality within 30 days               No     758 99.2 762 99.7 0.26 
                      Yes    6 0.8 2 0.3   
              
Re-exploration for bleeding No     737 96.5 753 98.6 0.01 
                      Yes    27 3.5 11 1.4   
              
Postoperative CVA               No     759 99.3 759 99.3 1 
                      Yes    5 0.7 5 0.7   
              
Postoperative RRT No     752 98.4 758 99.2 0.24 
                      Yes    12 1.6 6 0.8   
              
Postoperative IABP             No     754 98.7 762 99.7 0.04 
                      Yes    10 1.3 2 0.3   
              
SW reconstruction     No     757 99.1 763 99.9 0.07 
                      Yes    7 0.9 1 0.1   
              
Length of hospital stay mean±sd 7.1±5.1  6.6±3.7  0.05  
  [ 2,10) 676 88.5 691 90.4  
                      [10,75] 88 11.5 73 9.6   
RITA: right internal thoracic artery; RA: radial artery; PSM: propensity score matched; 
CVA: cerebrovascular accident; RRT renal replacement therapy; IABP: intra-aortic 
balloon pump; SW: sternal wound  
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Supplementary  Table 1. Missing data rate 
Variable  Count % 
   
Age  0 0% 
Female  0 0% 
MI  12 0.4% 
PCI  5 0.2% 
DM  10 0.4% 
Current smoking  9 0.3% 
Creatinine>200 mmol/l  8 0.3% 
COPD  9 0.3% 
CVA  24 0.9% 
PVD  9 0.3% 
AF  8 0.3% 
LMD  203 7.3% 
LVEF  27 0.9% 
Preoperative IABP  17 0.6% 
OPCAB  40 1.4% 
Non elective priority  1 0.03% 
BMI  198 7.1% 
Performed by resident  1 0.03% 
Logistic EuroSCORE  0 0% 
Year Of Surgery   0 0% 
LAD 0 0% 
DIA 0 0% 
CX 0 0% 
RCA 0 0% 
BMI: body mass index; MI: myocardial infarction; PCI: percutaneous coronary intervention; DM: 
diabetes mellitus; COPD: chronic obstructive pulmonary disease; CVA: cerebrovascular accident; PVD: 
peripheral vascular disease; AF: atrial fibrillation; LVEF: left ventricular ejection fraction; IABP: intra-
aortic balloon pump; LMS: left main stem; LAD: left anterior descending artery; RCA: right coronary 
artery; CX: circumflex artery; DIA: diagonal; OPCAB: off-pump coronary artery bypass grafting.   
29 
 
Figure legend 
Central picture. Kaplan-Meier survival curve probabilities in the right internal thoracic 
artery (RITA) and the radial artery (RA) groups in the propensity score matched 
population.  
Figure 1. Graphical visualization of standardized mean difference before after 
propensity score matching 
(BMI: body mass index; MI: myocardial infarction; PCI: percutaneous coronary 
intervention; DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; 
CVA: cerebrovascular accident; PVD: peripheral vascular disease; AF: atrial 
fibrillation; LVEF: left ventricular ejection fraction; IABP: intra-aortic balloon pump; 
LMS: left main stem; RCA: right coronary artery; CX: circumflex artery; DIA: diagonal; 
OPCAB: off-pump coronary artery bypass grafting).  
Figure 2. Kaplan-Meier survival curve probabilities in the right internal thoracic artery 
(RITA) and the radial artery (RA) groups in the propensity score matched population.  
Figure 3. PS-adjusted Cox model survival curve probabilities in the right internal 
thoracic artery (RITA) and the radial artery (RA) groups according to the experimental 
conduit target 
Figure 4. PS-adjusted Cox model survival curve probabilities in the right internal 
thoracic artery (RITA) and the radial artery (RA) groups with the experimental conduit 
grafted to the left coronary system according to different RITA graft configuration.  
Supplementary Figure 1. Number of procedures per year performed by using the RITA 
or the RA as second arterial conduit during the study period. (RITA: right internal 
thoracic artery; RA: radial artery)   
Supplementary Figure 2. Graphical visualization of missing data rates and 
combinations  
Supplementary Figure 3. Area under the curve for the Propensity Score model  
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Supplementary Figure 4. Number of procedures per year performed off-pump during 
the study period (OPCAB: off-pump coronary artery bypass; ONCAB: on-pump  
coronary artery bypass) 
Supplementary Figure 5. Schoenfeld residuals visualization to check the proportional 
hazard assumption for the treatment variable on late mortality (beyond 4 years). 
Supplementary Figure 6. Kaplan-Meier survival curve probabilities in the unmatched 
radial artery (RA) groups.  
Supplementary Figure 7. PS-adjusted Cox model survival curve probabilities in the 
right internal thoracic artery (RITA) and the radial artery (RA) groups with the 
experimental conduit grafted to the right coronary system according to different RITA 
graft configuration.  
Video 1. Radial artery grated to the circumflex artery during off-pump coronary artery 
bypass 
